Indivior's surprise $290 million provision highlights litigation risks
Indivior £15.99Loss to date: 6.8%Consistent upgrades to earnings from both the company and analysts resulting from strong growth in OUD (opioid use disorder) treatment Sublocade prompted us to turn positive on Indivior (INDV) in...
23 February 2023
